BioLife Solutions, Inc. inaugurated the Aby J. Mathew Center for Biopreservation Excellence in its Bothell headquarters on November 20, 2025. The 4,500‑square‑foot facility blends conference space with laboratory capabilities, creating a hub for training, collaborative research, and product demonstrations that showcase the company’s cell‑processing portfolio.
The center is named after Aby J. Mathew, Ph.D., the company’s Executive Vice President and Chief Scientific Officer, who pioneered BioLife’s proprietary biopreservation media and established its manufacturing and quality systems. The naming underscores Mathew’s foundational role in building the company’s core technology platform and signals a continued commitment to scientific leadership.
The new center follows BioLife’s April 2025 acquisition of PanTHERA CryoSolutions, which brought ice‑recrystallization inhibitor (IRI) technology into the company’s product line. Integrating IRI into BioLife’s media enhances cryopreservation performance, a key differentiator in the rapidly expanding cell and gene therapy (CGT) market. The center will host workshops and customized training that leverage this technology, positioning BioLife to accelerate next‑generation cryopreservation solutions.
BioLife’s Q3 2025 earnings, released shortly before the center’s opening, highlighted a 33% year‑over‑year increase in Cell Processing revenue to $28.07 million, driven by strong demand from CGT manufacturers. The company raised its full‑year 2025 revenue guidance to $95.0 million–$96.0 million, with Cell Processing revenue expected to reach $93.0 million–$94.0 million. The divestiture of the evo Cold Chain Logistics subsidiary freed resources that now support the new center’s research and development initiatives.
CEO Roderick de Greef emphasized that the center “fosters customer success through collaborative process development with our biopreservation and cell‑processing experts.” He noted that aligning the organization around the high‑margin Cell Processing business is driving sustainable growth and expanding profitability, a strategy that the new center will reinforce by deepening customer relationships and accelerating innovation in biopreservation.
The opening of the Aby J. Mathew Center signals BioLife’s continued investment in core technologies that underpin its high‑margin business and positions the company to capture growing demand in the CGT ecosystem. The facility’s focus on training, research, and collaboration is expected to strengthen BioLife’s competitive edge and support the company’s long‑term growth trajectory.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.